Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer

被引:10
|
作者
Miasaki, Fabiola Yukiko [1 ]
Fuziwara, Cesar Seigi [2 ]
Carvalho, Gisah Amaral de [1 ]
Kimura, Edna Teruko [2 ]
机构
[1] Univ Fed Parana, Dept Endocrinol & Metab SEMPR, Hosp Clin, BR-80030110 Curitiba, Parana, Brazil
[2] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508000 Sao Paulo, Brazil
关键词
thyroid cancer; thyroid neoplasms; genetic predisposition to disease; genetic variants; CRIBRIFORM-MORULAR VARIANT; TUMOR-SUPPRESSOR GENE; MULTINODULAR GOITER; GERMLINE MUTATION; DICER1; MUTATIONS; COMMON VARIANTS; WERNER-SYNDROME; CLINICAL MANAGEMENT; LINKAGE ANALYSIS; APC GENE;
D O I
10.3390/genes11111364
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Thyroid cancer is the most frequent endocrine malignancy with the majority of cases derived from thyroid follicular cells and caused by sporadic mutations. However, when at least two or more first degree relatives present thyroid cancer, it is classified as familial non-medullary thyroid cancer (FNMTC) that may comprise 3-9% of all thyroid cancer. In this context, 5% of FNMTC are related to hereditary syndromes such as Cowden and Werner Syndromes, displaying specific genetic predisposition factors. On the other hand, the other 95% of cases are classified as non-syndromic FNMTC. Over the last 20 years, several candidate genes emerged in different studies of families worldwide. Nevertheless, the identification of a prevalent polymorphism or germinative mutation has not progressed in FNMTC. In this work, an overview of genetic alteration related to syndromic and non-syndromic FNMTC is presented.
引用
收藏
页码:1 / 21
页数:21
相关论文
共 50 条
  • [21] Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients
    Capezzone, Marco
    Sagnella, Alfonso
    Cantara, Silvia
    Fralassi, Noemi
    Maino, Fabio
    Forleo, Raffaella
    Brilli, Lucia
    Pilli, Tania
    Cartocci, Alessandra
    Castagna, Maria Grazia
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [22] Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer
    Hincza, Kinga
    Kowalik, Artur
    Kowalska, Aldona
    GENES, 2019, 10 (07)
  • [23] Novel truncating germline variant reinforces TINF2 as a susceptibility gene for familial non-medullary thyroid cancer
    Oriola, Josep
    Diez, Orland
    Mora, Mireia
    Halperin, Irene
    Martinez, Sandra
    Masas, Miriam
    Tenes, Anna
    Bernal, Anna
    Duran, Rafael
    Orois, Aida
    JOURNAL OF MEDICAL GENETICS, 2024, 61 (10) : 939 - 942
  • [24] Thyroid Cancer Genetics: Multiple Endocrine Neoplasia Type 2, Non-Medullary Familial Thyroid Cancer, and Familial Syndromes Associated with Thyroid Cancer
    Richards, Melanie L.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 18 (01) : 39 - +
  • [25] The impact of family history on non-medullary thyroid cancer
    Nixon, I. J.
    Suarez, C.
    Simo, R.
    Sanabria, A.
    Angelos, P.
    Rinaldo, A.
    Rodrigo, J. P.
    Kowalski, L. P.
    Hartl, D. M.
    Hinni, M. L.
    Shah, J. P.
    Ferlito, A.
    EJSO, 2016, 42 (10): : 1455 - 1463
  • [26] Prioritization of predisposition genes for familial non-medullary thyroid cancer by whole-genome sequencing
    Srivastava, Aayushi
    Skopelitou, Diamanto
    Miao, Beiping
    Giagiobbe, Sara
    Paramasivam, Nagarajan
    Kumar, Abhishek
    Diquigiovanni, Chiara
    Bonora, Elena
    Bandapalli, Obul Reddy
    Foersti, Asta
    Hemminki, Kari
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2025, 192 (04) : 398 - 407
  • [27] Familial Non-Medullary Thyroid Carcinoma in Pediatric Age: Our Surgical Experience
    Spinelli, Claudio
    Piccolotti, Irene
    Bertocchini, Alessia
    Morganti, Riccardo
    Materazzi, Gabriele
    Tonacchera, Massimo
    Strambi, Silvia
    WORLD JOURNAL OF SURGERY, 2021, 45 (08) : 2473 - 2479
  • [28] Identification of P21 (CDKN1A) Activated Kinase 4 as a Susceptibility Gene for Familial Non-Medullary Thyroid Carcinoma
    Jiang, Yu-Jia
    Xia, Yun
    Hu, Yi-Xuan
    Han, Zhuo-Jun
    Guo, An-Yuan
    Huang, Tao
    THYROID, 2024, 34 (05) : 583 - 597
  • [29] Identification of NID1 as a novel candidate susceptibility gene for familial non-medullary thyroid carcinoma using whole-exome sequencing
    Barbalho de Mello, Luis Eduardo
    Ribeiro Carneiro, Thaise Nayane
    Araujo, Aline Neves
    Alves, Camila Xavier
    Favoretto Galante, Pedro Alexandre
    Buzatto, Vanessa Candiotti
    de Almeida, Maria das Gracas
    Vermeulen-Serpa, Karina Marques
    de Lima Vale, Sancha Helena
    de Pinto Paiva, Fernando Jose
    Brandao-Neto, Jose
    Cerutti, Janete Maria
    ENDOCRINE CONNECTIONS, 2022, 11 (01)
  • [30] Familial non-medullary thyroid cancer represents an independent risk factor for increased cancer aggressiveness: a retrospective analysis of 74 families
    Tavarelli, Martina
    Russo, Marco
    Terranova, Rosy
    Scollo, Claudia
    Spadaro, Angela
    Sapuppo, Giulia
    Malandrino, Pasqualino
    Masucci, Romilda
    Squatrito, Sebastiano
    Pellegriti, Gabriella
    FRONTIERS IN ENDOCRINOLOGY, 2015, 6